Milestone Pharmaceuticals Inc. (MIST) Operating income 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual operating income history from SEC filings — each fiscal year as reported.
-$62.1MFY2025 · since FY2018: -$23.8M → -$62.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.1M | -47.6% |
| FY2024 | -$42.1M | +31.1% |
| FY2023 | -$61.1M | -2.4% |
| FY2022 | -$59.6M | -38.5% |
| FY2021 | -$43.1M | +15.1% |
| FY2020 | -$50.7M | +12.4% |
| FY2019 | -$57.9M | -143.0% |
| FY2018 | -$23.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice